Click a link below to view the mailing archive as if it had been sent to you.
| 2022-03-31 12:15 | | An FDA panel reviewing Amylyx's ALS drug was moved by patient testimony—but they voted it down anyway and more... |
| 2022-03-30 12:15 | | Novo Nordisk snags high-dose Ozempic approval, turning up the heat on Lilly's Trulicity and more... |
| 2022-03-30 00:15 | | U.S. approves second Covid-19 booster for people 50 and older and more... |
| 2022-03-29 12:15 | | New blow for ALS pipeline as Biogen and Ionis candidate fails Phase 1 trial and more... |
| 2022-03-29 00:15 | | U.S. Senate to Take Up Proposed $35 Insulin Cap this Spring and more... |
| 2022-03-28 12:15 | | 'Stay alive': Wave of layoffs crashes into biotech startup inferno and more... |
| 2022-03-28 00:15 | | Officials limit an antibody therapy, saying it’s ineffective against BA.2 variant of Omicron and more... |
| 2022-03-25 12:15 | | After layoffs, Gilead to build NJ hub that will employ up to 500 and more... |
| 2022-03-25 00:15 | | Sun Pharma forks over $485M to settle long-running legal battle inherited in Ranbaxy buyout and more... |
| 2022-03-24 12:15 | | AstraZeneca's Imfinzi Fails to Boost Survival in Cervical Cancer and more... |
| 2022-03-24 00:15 | | Pharma’s ambition in connected health not yet matched by execution and more... |
| 2022-03-23 12:15 | | 2seventy bio's honeymoon phase is over as job cuts hit 6% of staff and more... |
| 2022-03-23 00:15 | | Fujifilm to acquire Shenandoah Biotechnology and more... |
| 2022-03-22 12:15 | | Moderna trains its mRNA tech on the common cold and a triple whammy against 3 respiratory diseases and more... |
| 2022-03-22 00:15 | | AstraZeneca antibody drug effective against BA.2, study finds and more... |
| 2022-03-21 12:15 | | U.S. FDA advisers to discuss COVID vaccine boosters in April and more... |
| 2022-03-21 00:15 | | BMS Celebrates A New Day in Cancer Treatment with Approval of Opdualag and more... |
| 2022-03-18 12:15 | | Moderna seeks FDA authorization for a second booster dose of its coronavirus vaccine for all adults and more... |
| 2022-03-18 00:15 | | AstraZeneca prepared to ditch effort to secure US approval for Covid vaccine and more... |
| 2022-03-17 12:15 | | GSK falls in line with Big Pharma's reaction to Ukraine invasion, cutting off new clinical trials, donating profits and more and more... |
| 2022-03-17 00:15 | | How Moderna helped RNA drugs come of age and more... |
| 2022-03-16 12:15 | | Sanofi steps off the sidelines to ink 3 ADC deal with Seagen, reigniting long-held interest in the modality and more... |
| 2022-03-16 00:15 | | Merck Announces Ups and Downs Involving Blockbuster Keytruda and more... |
| 2022-03-15 12:15 | | Eisai hands off responsibility for Aduhelm to Biogen and more... |
| 2022-03-15 00:15 | | Covid fears can still inspire big market rallies for the mRNA pioneers — and fast fizzles and more... |
| 2022-03-14 12:15 | | Pfizer pledges to donate all Russian profits to humanitarian causes amid war in Ukraine and more... |
| 2022-03-14 01:15 | | Novavax aims for name recognition in new vaccines campaign and more... |
| 2022-03-14 00:15 | | Novavax aims for name recognition in new vaccines campaign and more... |
| 2022-03-11 12:15 | | Amid inflation spike, execs at J&J, Bayer, GSK and more talk higher costs—and what it means for profits and more... |
| 2022-03-11 00:15 | | How the Biopharma Workforce is Shaping the Future and more... |
| 2022-03-10 12:15 | | Moderna CEO's Salary Spikes while the Median Employee's Falls and more... |
| 2022-03-10 00:15 | | Pfizer will soon provide data to U.S. FDA on fourth COVID shot - Bloomberg and more... |
| 2022-03-09 12:15 | | FDA's oncology adcomm to review PI3K inhibitors in blood cancers in April and more... |
| 2022-03-09 00:15 | | Gilead Sciences will lay off 114 staffers based out of former Immunomedics headquarters and more... |
| 2022-03-08 12:15 | | COVID vaccines not linked to excess deaths, says new CDC study and more... |
| 2022-03-08 00:15 | | Ukraine pharma CEO urges the industry to rally behind his country on three fronts and more... |
| 2022-03-07 12:15 | | AstraZeneca to tack on another $100M to wrap up over-budget R&D center and more... |
| 2022-03-07 00:15 | | bluebird says future uncertain as delays to gene therapies bite and more... |
| 2022-03-04 12:15 | | 75% of infusion pumps have cyber flaws, putting them at risk from hackers: study and more... |
| 2022-03-04 00:15 | | Bristol Myers Squibb to consolidate R&D units in San Diego in new complex and more... |
| 2022-03-03 12:15 | | Novo Nordisk, citing strong Wegovy demand, doubles 2025 sales target for obesity franchise and more... |
| 2022-03-03 00:15 | | Facing omicron 'curveball,' Inovio seeks endpoint switch amid fear it will strike out against original goal and more... |
| 2022-03-02 12:15 | | Eli Lilly's Medicaid rebate payments under fire as whistleblower lawsuit heads to trial and more... |
| 2022-03-02 00:15 | | CDC data suggest Pfizer vaccine protection holds up in kids 5-11, raising questions on earlier study and more... |
| 2022-03-01 12:15 | | AbbVie bets $130M on UCB spinout, bagging early-phase Alzheimer's and depression prospect and more... |
| 2022-03-01 00:15 | | Intellia presses forward with new results for pioneering CRISPR drug and more... |
